Avise Analytics is the fastest growing equity research firm that authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies that are undervalued and lacks adequate coverage.
Our team of highly experienced analysts provides a wide range of tailored services in the field of equity, investment and financial research and investor relations to our diversified client base around the world.
Our free mobile app gives you real-time notifications on publication of short company stories for compelling investment ideas so that you never miss an opportunity!
As a step to effectively handle your research team’s workload as a business partner, our free mobile (and tablet friendly) application, also offer you a complete accessibility in tracking your project progress and billing and payment status at the tip of your finger any time.
Download the app for free now to explore our talent pool and feel the difference in outsourcing your work to us.
We pride ourselves in constantly delivering high-quality and scalable equity, investment and credit research solutions to our diversified client base across 9 countries. A snapshot of our key experience in past 3 years includes:
Adverum Biotechnologies (NASDAQ: ADVM), a clinical-stage Company focused on developing therapeutics for ocular and rare ...18 October, 2019No comment
The U.S Healthcare system is estimated to be a $3.2 trillion market comprising of various stakeholders such as hospitals...17 October, 2019No comment
In a considerable setback, Aphria (NYSE: APHA), one of the largest cannabis companies in the world, has lost a supply de...16 October, 2019No comment
Sandhoff Disease also referred to as GM2-gangliosidosis Type ll is an autosomal recessive genetic lipid storage disorde...15 October, 2019No comment
NexTech AR Solutions (OTCQB: NEXCF), a leader in the fast emerging Augmented Reality Industy, announced the signing of a...14 October, 2019No comment
Puration Inc (OTCPINK: PURA), a leading CBD infused sports drink maker, which produces the EVERx CBD beverage, announced...14 October, 2019No comment
Otonomy Inc (NASDAQ: OTIC), a biopharmaceutical company focussed on providing neurotology solutions, announced a strateg...10 October, 2019No comment
AzurRx BioPharma (NASDAQ: AZRX), a development stage company that is developing oral, nonsystemic, recombinant proteins ...09 October, 2019No comment
Aravive, Inc. (NASDAQ: ARAV), a clinical stage biotechnology Company engaged in developing therapeutics for solid tumour...09 October, 2019No comment
The U.S House of Representatives passed a landmark legislation namely Secure And Fair Enforcement (SAFE) Banking Act (H....01 October, 2019No comment
Menlo Therapeutics (NASDAQ: MNLO), a late-stage biopharmaceutical company, has announced the completion of enrollment of...30 September, 2019No comment
The Global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by Grand ...27 September, 2019No comment
Blink Charging (NASDAQ: BLNK), a provider of Electric Vehicle (EV) charging equipment, announced its foray into Greece...26 September, 2019No comment
vTv Therapeutics (NASDAQ: VTVT), a clinical stage biotechnology company, presented additional positive data from a phase...25 September, 2019No comment
The Food and Drug Administration of America (FDA) has initiated a criminal investigation into the supply chain of Cannab...24 September, 2019No comment
Avise Analytics is a professionally managed organization and understood job scopes & requirements very well. The report and analysis generated meet my expectations and will not hesitate to recommend others.
Delivered a high-quality set of documents that exceeded my expectations. Keep up the good work!!
Great team. We ramped up our coverage universe quickly due to their help. I highly recommend them!
High quality equity research provider that we now use for regular work
Excellent communication skills and a high commitment to client satisfaction.
Instrumental in helping us complete the research in such a tight timeline!
I have found Avise Analytics to be a great, cost-effective solution to providing both simple and complex finance-related articles for various blogs and newsletters. They are detailed oriented, consciences, respond well to direction, prompt and really know the finance industry.